Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ellen E. Brodin"'
Autor:
Håkon S. Johnsen, Kristian Hindberg, Esben Bjøri, Ellen E. Brodin, Sigrid K. Brækkan, Vânia M. Morelli, John-Bjarne Hansen
Publikováno v:
TH Open, Vol 03, Iss 01, Pp e77-e84 (2019)
Identification of patients at risk of major bleeding is pivotal for optimal management of anticoagulant therapy in venous thromboembolism (VTE). Studies have suggested that D-dimer may predict major bleeding during anticoagulation; however, this is s
Externí odkaz:
https://doaj.org/article/1a91fd98aac84bda8af98e6a2c6b7846
Publikováno v:
Haematologica, Vol 97, Iss 7 (2012)
Background Previous studies have shown an association between impaired kidney function, assessed by cystatin C-based estimated glomerular filtration rate, and venous thromboembolism. The aim of this study was to investigate whether serum cystatin C w
Externí odkaz:
https://doaj.org/article/8029c53e699c4ce1825dee08a39047b3
Autor:
Bakhtawar K Mahmoodi, Ron T Gansevoort, Inger Anne Naess, Pamela L Lutsey, Sigrid K Braekkan, Nic J Veeger, Ellen E Brodin, Karina Meijer, Yingying Sang, Kunihiro Matsushita, Stein Hallan, Jens Hammerstrøm, Brad C Astor, Josef Coresh, Aaron R Folsom, John-Bjarne Hansen, Mary Cushman
Publikováno v:
Circulation. 125
Background: Recent findings suggest that mild chronic kidney disease (CKD) might be associated with increased risk of venous thromboembolism (VTE). However, results were partially inconsistent, which may be due to lack of power. We therefore performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db467c944800be490bdf3fa779029d50
https://doi.org/10.1161/circ.125.suppl_10.ap255
https://doi.org/10.1161/circ.125.suppl_10.ap255
Autor:
Riise J; Department of Oncology, Oslo University Hospital, Oslo, Norway., Meyer S; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Blaas I; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Chopra A; Department of Immunology, Oslo University Hospital, Oslo, Norway., Tran TT; Department of Immunology, Oslo University Hospital, Oslo, Norway., Delic-Sarac M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hestdalen ML; Department of Hematology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Brodin E; Hematological Research Group, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Rustad EH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Hematological Research Group, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Dai KZ; Department of Immunology, Oslo University Hospital, Oslo, Norway., Vaage JT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Nissen-Meyer LSH; Department of Immunology, Oslo University Hospital, Oslo, Norway., Sund F; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Wader KF; Department of Oncology, St Olav University Hospital, Trondheim, Norway., Bjornevik AT; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Meyer PA; Department of Oncology and Hematology, Stavanger University Hospital, Stavanger, Norway., Nygaard GO; Department of Neurology, Oslo University Hospital, Oslo, Norway., König M; Department of Neurology, Oslo University Hospital, Oslo, Norway., Smeland S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway.; ImmunoLingo Convergence Center, University of Oslo, Oslo, Norway., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Kolstad A; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Jun; Vol. 197 (6), pp. 697-708. Date of Electronic Publication: 2022 Mar 21.
Autor:
Ghanima W; Department of Medicine, Østfold Hospital, Grålum, Norway; Department of Hematology, Østfold Hospital, Grålum, Norway; Department of Research, Østfold Hospital, Grålum, Norway; Department of Haematology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: Waleed.Ghanima@so-hf.no., Schultze A; Evidera, London, United Kingdom., Donaldson R; Hematological Research Group, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Brodin E; Hematological Research Group, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Halvorsen S; Department of Haematology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cardiology, Oslo University Hospital Ulleval and University of Oslo, Oslo, Norway., Graham S; Hematological Research Group, Division of Medicine, Akershus University Hospital, Lørenskog, Norway., Carroll R; Bristol-Myers Squibb, Uxbridge, United Kingdom., Ulvestad M; Bristol-Myers Squibb, Lysaker, Norway., Lambrelli D; Evidera, London, United Kingdom.
Publikováno v:
Clinical therapeutics [Clin Ther] 2021 Jul; Vol. 43 (7), pp. 1179-1190.e3. Date of Electronic Publication: 2021 Jun 01.
Autor:
Ghanima W; Departments of Medicine, Hematology and Research, Østfold Hospital, Oslo, Norway; Department of Haematology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: Waleed.Ghanima@so-hf.no., Brodin E; Hematological Research Group, Division of Medicine, Akershus University Hospital, Lørenskog, Norway. Electronic address: Ellen.Brodin@ahus.no., Schultze A; Evidera, The Ark, 201 Talgarth Road, Hammersmith, London W6 8BJ, United Kingdom. Electronic address: Anna.Schultze@lshtm.ac.uk., Shepherd L; Evidera, The Ark, 201 Talgarth Road, Hammersmith, London W6 8BJ, United Kingdom. Electronic address: leah.shepherd@sydney.edu.au., Lambrelli D; Evidera, The Ark, 201 Talgarth Road, Hammersmith, London W6 8BJ, United Kingdom. Electronic address: dimitra.lambrelli@evidera.com., Ulvestad M; Bristol-Myers Squibb, Lysaker, Norway. Electronic address: Maria.Ulvestad@bms.com., Ramagopalan S; Bristol-Myers Squibb, Uxbridge, United Kingdom. Electronic address: sreeram.ramagopalan@roche.com., Halvorsen S; Department of Haematology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cardiology, Oslo University Hospital Ulleval and University of Oslo, Oslo, Norway. Electronic address: sigrun.h@online.no.
Publikováno v:
Thrombosis research [Thromb Res] 2020 Nov; Vol. 195, pp. 165-168. Date of Electronic Publication: 2020 Jul 07.
Autor:
Garabet L; Multidisciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital, Norway; Department of Research, Østfold Hospital Trust, Norway; Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: lamyagarabet@hotmail.com., Henriksson CE; Institute of Clinical Medicine, University of Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital, Norway., Lozano ML; Hospital JM Morales Meseguer, Centro Regional de Hemodonacion, IMIB-Arrixaca, Murcia, Spain; Grupo de investigación CB15/00055 del Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Ghanima W; Department of Research, Østfold Hospital Trust, Norway; Institute of Clinical Medicine, University of Oslo, Norway., Bussel J; New York Presbyterian Hospital, Weill Cornell, United States., Brodin E; Department of Haematology, Akershus University Hospital, Norway., Fernández-Pérez MP; Hospital JM Morales Meseguer, Centro Regional de Hemodonacion, IMIB-Arrixaca, Murcia, Spain., Martínez C; Hospital JM Morales Meseguer, Centro Regional de Hemodonacion, IMIB-Arrixaca, Murcia, Spain., González-Conejero R; Hospital JM Morales Meseguer, Centro Regional de Hemodonacion, IMIB-Arrixaca, Murcia, Spain., Mowinckel MC; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Department of Haematology, Oslo University Hospital, Norway., Sandset PM; Institute of Clinical Medicine, University of Oslo, Norway; Research Institute of Internal Medicine, Oslo University Hospital, Norway; Department of Haematology, Oslo University Hospital, Norway.
Publikováno v:
Thrombosis research [Thromb Res] 2020 Jan; Vol. 185, pp. 119-124. Date of Electronic Publication: 2019 Nov 30.
Autor:
Sølvik UØ; Department of Global Public Health and Primary Care, Faculty of Medicine, University of Bergen, Bergen, Norway., Løkkebø E; Norwegian Organization of Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway., Kristoffersen AH; Norwegian Organization of Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.; Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway., Brodin E; Division of Medicine, Department of Hematology, Akershus University Hospital, Lørenskog, Norway., Averina M; Department of Laboratory Medicine, The University Hospital of North Norway, Tromsø, Norway., Sandberg S; Department of Global Public Health and Primary Care, Faculty of Medicine, University of Bergen, Bergen, Norway.; Norwegian Organization of Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.; Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2019 Oct; Vol. 119 (10), pp. 1632-1641. Date of Electronic Publication: 2019 Aug 01.
Publikováno v:
Thrombosis research [Thromb Res] 2012 Oct; Vol. 130 (4), pp. e236-7. Date of Electronic Publication: 2012 Aug 19.
Autor:
Brodin E; Hematological Research Group (HERG), Department of Clinical Medicine, University of Tromsø, Tromsø, Norway. ellen.brodin@uit.no, Vikan T, Hansen JB, Svartberg J
Publikováno v:
Seminars in thrombosis and hemostasis [Semin Thromb Hemost] 2011 Feb; Vol. 37 (1), pp. 87-94. Date of Electronic Publication: 2011 Jan 19.